| Financial Year |
March 31 2023 |
| Monetary Funds |
312,093,591.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
19,355,516.92 |
| Accounts Receivable |
210,923,595.23 |
| Advances to Suppliers |
8,702,041.42 |
| Other Receivables |
9,873,574.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
136,485,496.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,700,649.63 |
| Total Current Assets |
727,001,018.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,701,306.93 |
| Fixed Assetes |
12,397,410.07 |
| Under-construction Projects |
160,899,990.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,734,952.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,279.26 |
| Deferred Income Tax Assets |
7,084,718.40 |
| Other Non-Current Assets |
4,953,878.40 |
| Sub-Total of Non-Current Assets |
211,012,219.83 |
| Total Assets |
938,013,238.56 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,257,877.28 |
| Accounts Payable |
45,405,120.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,235,730.58 |
| Taxes Payable |
2,853,204.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,223,476.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,265,545.85 |
| Other Current Liabilities |
4,696,123.99 |
| Sub-Total of Current Liabilities |
144,776,656.91 |
| Long-term Loans |
21,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,196,402.80 |
| Total Liabilities |
165,973,059.71 |
| Paid-In Capital(Or Share Stock) |
110,827,200.00 |
| Capital Surplus |
402,141,406.17 |
| Surplus Reserve |
31,855,183.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
225,679,874.20 |
| Minority Stockholder's Interest |
1,536,515.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
770,503,663.81 |
| Owner's Equity（Stockholder's Equity） |
772,040,178.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
938,013,238.56 |
